189 related articles for article (PubMed ID: 5002621)
1. [Penicillamine in the light of current clinical research].
Beritić T; Dimov
Lijec Vjesn; 1970 Dec; 92(12):1449-53. PubMed ID: 5002621
[No Abstract] [Full Text] [Related]
2. [D(-)penicillamine: pharmacology and clinical uses].
Gattoni A; De Donato MT; Catalano G; Astarita C; Bernabò R; Altucci P
Clin Ter; 1982 Nov; 103(4):411-44. PubMed ID: 6217944
[No Abstract] [Full Text] [Related]
3. [Effects and adverse effects of D-penicillamine].
Perings E; Junge U
Med Klin; 1975 Aug; 70(31):1265-74. PubMed ID: 1107780
[No Abstract] [Full Text] [Related]
4. Penicillamine in metal poisoning.
Lyle WH
J Rheumatol Suppl; 1981; 7():96-9. PubMed ID: 6939892
[TBL] [Abstract][Full Text] [Related]
5. [D-penicillamine therapy of chronic polyarthritis].
Günther R; Gabl F; Knapp E
Z Rheumaforsch; 1973; 32(7):313-25. PubMed ID: 4741805
[No Abstract] [Full Text] [Related]
6. D-penicillamine in the treatment of rheumatoid arthritis and progressive systemic sclerosis.
Davis P; Bleehen SS
Br J Dermatol; 1976 Jun; 94(6):705-11. PubMed ID: 779821
[No Abstract] [Full Text] [Related]
7. Copper and taste sensitivity.
Nutr Rev; 1968 Jun; 26(6):175-7. PubMed ID: 4874926
[No Abstract] [Full Text] [Related]
8. [D-penicillamine and collagen].
Camus JP; Koeger AC
Ann Biol Clin (Paris); 1986; 44(3):296-9. PubMed ID: 3538948
[TBL] [Abstract][Full Text] [Related]
9. [Effect of penicillamine on pathological macroglobulins].
Schneider W
Munch Med Wochenschr; 1967 Mar; 109(10):531-5. PubMed ID: 4967533
[No Abstract] [Full Text] [Related]
10. Effect of penicillamine on human collagen and its possible application to treatment of scleroderma.
Harris ED; Sjoerdsma A
Lancet; 1966 Nov; 2(7471):996-9. PubMed ID: 4162669
[No Abstract] [Full Text] [Related]
11. [Therapeutic use of d-penicillamine].
Bogdanikowa B
Pol Tyg Lek; 1972 Oct; 27(41):1612-3. PubMed ID: 4581541
[No Abstract] [Full Text] [Related]
12. CURRENT THERAPEUTICS. 192. PENICILLAMINE.
WALSHE JM
Practitioner; 1963 Dec; 191():789-95. PubMed ID: 14084387
[No Abstract] [Full Text] [Related]
13. [Mode of action of D-penicillamine in chronic polyarthritis. 1. Protein synthesis inhibition in synovial fluid cells].
Bröll H; Altmann H; Kocsis R; Tausch G
Z Rheumatol; 1978; 37(1-2):51-5. PubMed ID: 629096
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of progressive scleroderma with D-penicillamine (Metalcaptase)].
Böni A; Pavelka K; Kludas M
Munch Med Wochenschr; 1969 Aug; 111(31):1580-4. PubMed ID: 5394493
[No Abstract] [Full Text] [Related]
15. [Chemica damage to the eye in industrial medicine].
Lange J
Ophthalmologica; 1969; 1-3(1):95-108. PubMed ID: 5810716
[No Abstract] [Full Text] [Related]
16. [Clinical effectiveness of D-penicillamine in chronic mercury poisoning].
Ali-zade KA; Alekperov II; Kasimova FS
Gig Tr Prof Zabol; 1976 Jun; (6):41-2. PubMed ID: 133877
[No Abstract] [Full Text] [Related]
17. [Long-term use of D-penicillamine in systemic scleroderma and rheumatoid arthritis].
Guseva NG; Trofimova TM; Oskilko TG; Panasiuk AF; Tarasenkova TA
Klin Med (Mosk); 1986 Jun; 64(6):44-50. PubMed ID: 3747436
[No Abstract] [Full Text] [Related]
18. [Biosynthesis of collagen and mode of action of D-penicillamine (author's transl)].
Moritz AJ
Wien Klin Wochenschr; 1975 Jan; 87(1):1-6. PubMed ID: 1130072
[TBL] [Abstract][Full Text] [Related]
19. [THE USE OF PENICILLAMINE AND N-ACETYL-DL-PENICILLAMINE AS AN ANTIDOTE IN COPPER, LEAD AND MERCURY POISONINGS].
VERVEEN G; ELSKAMP DM
Pharm Weekbl; 1964 May; 99():577-8. PubMed ID: 14146276
[No Abstract] [Full Text] [Related]
20. [THE USE OF PENICILLAMINE AND N-ACTYL-DL-PENICILLAMINE AS AN ANTIDOTE IN COPPER, LEAD AND MERCURY POISONINGS].
VERVEEN G; ELSKAMP DM
Pharm Weekbl; 1964 May; 99():547-54. PubMed ID: 14146274
[No Abstract] [Full Text] [Related]
[Next] [New Search]
